OpenVSafe by OpenVAERS
Search V-safe

L6M-49629-25156

2 vaccinations 4 coded responses 14 check-ins 4 free-text entries 1 call case
Sex
Female
Age at first dose
12-15
ZIP prefix
836 / ID
Registered
2021-11-02
Relationship
Child or adolescent in my care
Guardian
FAY-10196-66341
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-10-14
    Dose 1 — Pfizer-BioNTech
  2. 2021-11-02
    Registered in v-safe
  3. 2021-11-02
    Health check-in — day 14, dose 1, dependent
    Feeling: Good
    Adult check-in
  4. 2021-11-05
    Dose 2 — Pfizer-BioNTech
  5. 2021-11-06
    Health check-in — days 1–6 daily, dose 2, dependent
    Feeling: Good · Site: Pain · Headache, Fatigue or tiredness, Nausea
    Adult check-in
  6. 2021-11-07
    Health check-in — days 1–6 daily, dose 2, dependent
    Feeling: Good · None
    Adult check-in
  7. 2021-11-08
    Health check-in — days 1–6 daily, dose 2, dependent
    Feeling: Good · None
    Adult check-in
  8. 2021-11-09
    Health check-in — days 1–6 daily, dose 2, dependent
    Feeling: Good · None
    Adult check-in
  9. 2021-11-10
    Health check-in — days 1–6 daily, dose 2, dependent
    Feeling: Good · None
    Adult check-in
  10. 2021-11-12
    Health check-in — day 7, dose 2, dependent
    Feeling: Good · Headache · Be unable to work or attend school
    Adult check-in
  11. 2021-11-20
    Health check-in — day 14, dose 2, dependent
    Feeling: Good
    Adult check-in
  12. 2021-11-26
    Survey response — day 21, dose 2, dependent
    MedDRA: Rash, Self-medication, Urticaria — Feeling: Good
    Free text: 1 week 6 days after second vaccine developed hives/rash to face and hands. Required Benadryl to recover. Lasted 4 hours. No known allergies.
    MedDRA releases: 2024-11 · check-in free text available
  13. 2021-12-04
    Health check-in — day 28, dose 2, dependent
    Feeling: Good
    Adult check-in
  14. 2021-12-10
    Health check-in — day 35, dose 2, dependent
    Feeling: Good
    Adult check-in
  15. 2021-12-18
    Survey response — day 42, dose 2, dependent
    MedDRA: Headache, Pre-existing disease — Feeling: Good · Be unable to work or attend school
    Free text: More frequent headaches. Has baseline history of headaches.
    MedDRA releases: 2024-11 · check-in free text available
  16. 2022-02-06
    Survey response — 3 months, dose 2, dependent
    MedDRA: SARS-CoV-2 test positive — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities
    Free text: Tested positive for COVID
    MedDRA releases: 2024-11 · check-in free text available
  17. 2022-11-05
    Survey response — 12 months, dose 2, dependent
    MedDRA: Depression — Feeling: Good · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visit
    Free text: Depression
    MedDRA releases: 2024-11 · check-in free text available
  18. 2022-11-05
    Report sent to call center — 12 months, dose 2, dependent
    Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    Outpatient clinic or urgent care clinic visit · Emergency room or emergency department visit · 1 call case(s)
  19. 2022-11-07

Vaccinations

DoseDateManufacturerCo-administered
12021-10-14Pfizer-BioNTech No
22021-11-05Pfizer-BioNTech No

Call center

1 call center case

1 unsuccessful

See the call center timeline

Free text

Release 10 — day 21, dose 2, dependent

2021-11-26

Symptoms: 1 week 6 days after second vaccine developed hives/rash to face and hands. Required Benadryl to recover. Lasted 4 hours. No known allergies.

Release 10 — day 42, dose 2, dependent

2021-12-18

Symptoms: More frequent headaches. Has baseline history of headaches.

Release 11 — 3 months, dose 2, dependent

2022-02-06

Symptoms: Tested positive for COVID

Release 12 — 12 months, dose 2, dependent

2022-11-05

Symptoms: Depression

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDDepression · · ✓
SDHeadache · · ✓
SDPre-existing disease · · ✓
SDRash · · ✓
SDSARS-CoV-2 test positive · · ✓
SDSelf-medication · · ✓
SDUrticaria · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release